Boyd Steven
- SEC CIK
- 0001706140
No open-market purchases or sales filed in the past year.
Current role at each company
- AVTX Avalo Therapeutics, Inc.10% Owneras of Jun 28, 2023
- TENX Tenax Therapeutics, Inc.Director, 10% Owneras of May 19, 2022
- KPRX Kiora Pharmaceuticals Inc10% Owneras of Aug 3, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Boyd Steven as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AVTX Avalo Therapeutics, Inc.
10% Owner13 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 28, 2023 (view filing)6:12 PM ET | Jun 26-27 | 2 days | Armistice Capital, LLC and 2 others10% Owner | SSale | −3.68M | $0.5888 | −$2.17M | −83.4%731.5K after | 2 lots |
| Feb 9, 2023 (view filing)4:32 PM ET | Feb 7 | 2 days | Armistice Capital, LLC and 2 others10% Owner | PPurchase | +450.0K | – | – | +11.3%4.42M after | |
| Feb 9, 2023 (view filing)4:32 PM ET | Feb 7 | 2 days | Armistice Capital, LLC and 2 others10% Owner | PPurchase | +450.0K | – | – | –450.0K after | Derivative |
| Mar 14, 2022 (view filing)5:38 PM ET | Mar 10-14 | 4 days | Armistice Capital, LLC and 2 othersDirector, 10% Owner | PPurchase | +226.0K | $0.6723 | +$151.9K | +0.5%47.6M after | 3 lots |
| Mar 7, 2022 (view filing)6:09 PM ET | Mar 3-7 | 4 days | Armistice Capital, LLC and 2 othersDirector, 10% Owner | PPurchase | +510.0K | $0.6748 | +$344.1K | +1.1%47.4M after | 3 lots |
| Feb 28, 2022 (view filing)5:53 PM ET | Feb 24-25 | 4 days | Armistice Capital, LLC and 2 othersDirector, 10% Owner | PPurchase | +140.0K | $0.7986 | +$111.8K | +0.3%46.8M after | 2 lots |
| Feb 22, 2022 (view filing)6:37 PM ET | Feb 17-22 | 5 days | Armistice Capital, LLC and 2 othersDirector, 10% Owner | PPurchase | +288.0K | $0.804 | +$231.6K | +0.6%46.7M after | 3 lots |
| Jan 20, 2022 (view filing)6:14 PM ET | Jan 18-20 | 2 days | Armistice Capital, LLC and 2 othersDirector, 10% Owner | PPurchase | +312.0K | $0.8798 | +$274.5K | +0.7%46.4M after | 3 lots |
| Jan 14, 2022 (view filing)5:49 PM ET | Jan 12-14 | 2 days | Armistice Capital, LLC and 2 othersDirector, 10% Owner | PPurchase | +455.0K | $0.9951 | +$452.8K | +1.0%46.1M after | 3 lots |
| Jan 11, 2022 (view filing)6:18 PM ET | Jan 7-11 | 4 days | Armistice Capital, LLC and 2 othersDirector, 10% Owner | PPurchase | +645.0K | $0.9968 | +$642.9K | +1.4%45.6M after | 3 lots |
KPRX Kiora Pharmaceuticals Inc
10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 3, 2021 (view filing)5:09 PM ET | Jul 30-Aug 2 | 4 days | Armistice Capital, LLC and 2 others10% Owner | SSale | −261.0K | $2.48 | −$646.6K | −24.9%785.0K after | 2 lots |
| Jul 29, 2021 (view filing)7:59 PM ET | Jul 27-29 | 2 days | Armistice Capital, LLC and 2 othersDirector, 10% Owner | SSale | −3.15M | $4.61 | −$14.5M | −75.1%1.05M after | 7 lots |